Advisory Board on Radiation and Worker Health (ABRWH or the Advisory Board), Subcommittee for Dose Reconstruction Reviews (SDRR), National Institute for Occupational Safety and Health (NIOSH), 37861 [2017-17130]
Download as PDF
Federal Register / Vol. 82, No. 155 / Monday, August 14, 2017 / Notices
Leroy A. Richardson,
Chief, Information Collection Review Office,
Office of Scientific Integrity, Office of the
Associate Director for Science, Office of the
Director, Centers for Disease Control and
Prevention.
[FR Doc. 2017–17025 Filed 8–11–17; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Advisory Board on Radiation and
Worker Health (ABRWH or the
Advisory Board), Subcommittee for
Dose Reconstruction Reviews (SDRR),
National Institute for Occupational
Safety and Health (NIOSH)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
Centers for Disease Control and
Prevention (CDC), announces the
following meeting for the
aforementioned subcommittee. This
meeting is open to the public, but
without a public comment period. The
public is welcome to submit written
comments in advance of the meeting, to
the contact person below. Written
comments received in advance of the
meeting will be included in the official
record of the meeting. The public is also
welcome to listen to the meeting by
joining the teleconference at the USA
toll-free, dial-in number at 1–866–659–
0537 and the pass code is 9933701. The
conference line has 150 ports for callers.
DATES: The meeting will be held on
September 28, 2017, 10:30 a.m.–5:00
p.m., EDT.
ADDRESSES: Audio Conference Call via
FTS Conferencing. The USA toll-free
dial-in number is 1–866–659–0537 and
the pass code is 9933701.
FOR FURTHER INFORMATION CONTACT:
Theodore Katz, MPA, Designated
Federal Officer, NIOSH, CDC, 1600
Clifton Road, Mailstop E–20, Atlanta,
Georgia 30333, Telephone (513) 533–
6800, Toll Free 1 (800) CDC–INFO,
Email ocas@cdc.gov.
SUPPLEMENTARY INFORMATION:
Background: The Advisory Board was
established under the Energy Employees
Occupational Illness Compensation
Program Act of 2000 to advise the
President on a variety of policy and
technical functions required to
implement and effectively manage the
sradovich on DSK3GMQ082PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
18:24 Aug 11, 2017
Jkt 241001
new compensation program. Key
functions of the Advisory Board include
providing advice on the development of
probability of causation guidelines,
which have been promulgated by the
Department of Health and Human
Services (HHS) as a final rule; advice on
methods of dose reconstruction, which
have also been promulgated by HHS as
a final rule; advice on the scientific
validity and quality of dose estimation
and reconstruction efforts being
performed for purposes of the
compensation program; and advice on
petitions to add classes of workers to the
Special Exposure Cohort (SEC).
In December 2000, the President
delegated responsibility for funding,
staffing, and operating the Advisory
Board to HHS, which subsequently
delegated this authority to the CDC.
NIOSH implements this responsibility
for CDC. The charter was issued on
August 3, 2001, renewed at appropriate
intervals, rechartered on March 22, 2016
pursuant to Executive Order 13708, and
will expire on September 30, 2017.
Purpose: The Advisory Board is
charged with (a) providing advice to the
Secretary, HHS, on the development of
guidelines under Executive Order
13179; (b) providing advice to the
Secretary, HHS, on the scientific
validity and quality of dose
reconstruction efforts performed for this
program; and (c) upon request by the
Secretary, HHS, advise the Secretary on
whether there is a class of employees at
any Department of Energy facility who
were exposed to radiation but for whom
it is not feasible to estimate their
radiation dose, and on whether there is
reasonable likelihood that such
radiation doses may have endangered
the health of members of this class. The
Subcommittee for Dose Reconstruction
Reviews was established to aid the
Advisory Board in carrying out its duty
to advise the Secretary, HHS, on dose
reconstruction.
Matters To Be Considered: The agenda
for the Subcommittee meeting includes
the following dose reconstruction
program quality management and
assurance activities: Dose reconstruction
cases under review from Sets 14–23,
including the Oak Ridge sites (Y–12, K–
25, Oak Ridge National Laboratory),
Hanford, Feed Materials Production
Center (‘‘Fernald’’), Lawrence Livermore
National Laboratory, Mound Plant,
Rocky Flats Plant, Nevada Test Site,
Idaho National Laboratory, Savannah
River Site, Brookhaven National
Laboratory, Westinghouse, W.R. Grace,
Uranium Mill in Monticello, Ventron
Corporation, Weldon Springs Plant, and
other Department of Energy and
‘‘Atomic Weapons Employer’’ facilities.
PO 00000
Frm 00023
Fmt 4703
Sfmt 4703
37861
The agenda is subject to change as
priorities dictate.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 2017–17130 Filed 8–11–17; 8:45 am]
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
[CFDA Numbers: 93.581, 93.587, 93.612]
Request for Public Comment on the
Proposed Adoption of Administration
for Native Americans Program Policies
and Procedures
Administration for Native
Americans, ACF, HHS.
ACTION: Notice for public comment.
AGENCY:
Pursuant to Section 814 of the
Native American Programs Act of 1974
(NAPA), as amended, the
Administration for Native Americans
(ANA) is required to provide members
of the public an opportunity to
comment on proposed changes in
interpretive rules and general
statements of policy and to give notice
of the final adoption of such changes no
less than 30 days before such changes
become effective. In accordance with
notice requirements of NAPA, ANA
herein describes proposed interpretive
rules and general statements of policy
that relate to ANA’s funding
opportunities beginning in Fiscal Year
(FY) 2018. Changes to FY 2018 Funding
Opportunity Announcements (FOAs)
will be based on the following
previously published programs:
Environmental Regulatory Enhancement
(ERE) HHS–2017–ACF–ANA–NR–1221,
Native American Language Preservation
and Maintenance-Esther Martinez
Immersion (EMI) HHS–2017–ACF–
ANA–NB–1226, Native American
Language Preservation and Maintenance
(P&M) HHS–2017–ACF–ANA–NL–1235,
Social and Economic Development
Strategies (SEDS) HHS–2017–ACF–
ANA–NA–1236, Social and Economic
Development Strategies-Alaska (SEDS–
AK) HHS–2015–ACF–ANA–NK–0960,
SUMMARY:
E:\FR\FM\14AUN1.SGM
14AUN1
Agencies
[Federal Register Volume 82, Number 155 (Monday, August 14, 2017)]
[Notices]
[Page 37861]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2017-17130]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Advisory Board on Radiation and Worker Health (ABRWH or the
Advisory Board), Subcommittee for Dose Reconstruction Reviews (SDRR),
National Institute for Occupational Safety and Health (NIOSH)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the
Centers for Disease Control and Prevention (CDC), announces the
following meeting for the aforementioned subcommittee. This meeting is
open to the public, but without a public comment period. The public is
welcome to submit written comments in advance of the meeting, to the
contact person below. Written comments received in advance of the
meeting will be included in the official record of the meeting. The
public is also welcome to listen to the meeting by joining the
teleconference at the USA toll-free, dial-in number at 1-866-659-0537
and the pass code is 9933701. The conference line has 150 ports for
callers.
DATES: The meeting will be held on September 28, 2017, 10:30 a.m.-5:00
p.m., EDT.
ADDRESSES: Audio Conference Call via FTS Conferencing. The USA toll-
free dial-in number is 1-866-659-0537 and the pass code is 9933701.
FOR FURTHER INFORMATION CONTACT: Theodore Katz, MPA, Designated Federal
Officer, NIOSH, CDC, 1600 Clifton Road, Mailstop E-20, Atlanta, Georgia
30333, Telephone (513) 533-6800, Toll Free 1 (800) CDC-INFO, Email
ocas@cdc.gov.
SUPPLEMENTARY INFORMATION: Background: The Advisory Board was
established under the Energy Employees Occupational Illness
Compensation Program Act of 2000 to advise the President on a variety
of policy and technical functions required to implement and effectively
manage the new compensation program. Key functions of the Advisory
Board include providing advice on the development of probability of
causation guidelines, which have been promulgated by the Department of
Health and Human Services (HHS) as a final rule; advice on methods of
dose reconstruction, which have also been promulgated by HHS as a final
rule; advice on the scientific validity and quality of dose estimation
and reconstruction efforts being performed for purposes of the
compensation program; and advice on petitions to add classes of workers
to the Special Exposure Cohort (SEC).
In December 2000, the President delegated responsibility for
funding, staffing, and operating the Advisory Board to HHS, which
subsequently delegated this authority to the CDC. NIOSH implements this
responsibility for CDC. The charter was issued on August 3, 2001,
renewed at appropriate intervals, rechartered on March 22, 2016
pursuant to Executive Order 13708, and will expire on September 30,
2017.
Purpose: The Advisory Board is charged with (a) providing advice to
the Secretary, HHS, on the development of guidelines under Executive
Order 13179; (b) providing advice to the Secretary, HHS, on the
scientific validity and quality of dose reconstruction efforts
performed for this program; and (c) upon request by the Secretary, HHS,
advise the Secretary on whether there is a class of employees at any
Department of Energy facility who were exposed to radiation but for
whom it is not feasible to estimate their radiation dose, and on
whether there is reasonable likelihood that such radiation doses may
have endangered the health of members of this class. The Subcommittee
for Dose Reconstruction Reviews was established to aid the Advisory
Board in carrying out its duty to advise the Secretary, HHS, on dose
reconstruction.
Matters To Be Considered: The agenda for the Subcommittee meeting
includes the following dose reconstruction program quality management
and assurance activities: Dose reconstruction cases under review from
Sets 14-23, including the Oak Ridge sites (Y-12, K-25, Oak Ridge
National Laboratory), Hanford, Feed Materials Production Center
(``Fernald''), Lawrence Livermore National Laboratory, Mound Plant,
Rocky Flats Plant, Nevada Test Site, Idaho National Laboratory,
Savannah River Site, Brookhaven National Laboratory, Westinghouse, W.R.
Grace, Uranium Mill in Monticello, Ventron Corporation, Weldon Springs
Plant, and other Department of Energy and ``Atomic Weapons Employer''
facilities. The agenda is subject to change as priorities dictate.
The Director, Management Analysis and Services Office, has been
delegated the authority to sign Federal Register notices pertaining to
announcements of meetings and other committee management activities,
for both the Centers for Disease Control and Prevention and the Agency
for Toxic Substances and Disease Registry.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease
Control and Prevention.
[FR Doc. 2017-17130 Filed 8-11-17; 8:45 am]
BILLING CODE 4163-19-P